TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mach7 Technologies ( (AU:M7T) ) has issued an update.
Mach7 Technologies announced the results of its Annual General Meeting, where all resolutions were passed by a poll. Key resolutions included the adoption of the Remuneration Report, the re-election of Dr. Eliot Siegel as a Director, and the issuance of Performance Rights to CEO & Managing Director Ms. Teri Thomas. These outcomes reflect strong shareholder support and are likely to positively impact the company’s governance and strategic direction.
The most recent analyst rating on (AU:M7T) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is a company operating in the technology industry, focusing on providing innovative solutions for healthcare imaging and data management. The company is known for its advanced software products that enhance the efficiency and effectiveness of medical imaging workflows, catering primarily to healthcare providers and institutions.
Average Trading Volume: 263,916
Technical Sentiment Signal: Sell
Current Market Cap: A$97.51M
Learn more about M7T stock on TipRanks’ Stock Analysis page.